Wall Street Pros Say Hedge Funds Don't Need New Regulations

Wall Street money managers told a House committee on Tuesday that hedge funds should disclose more to their bankers and improve their risk management but not be subject to new regulations.

The House Financial Services Committee is conducting hearings on whether hedge funds should be more closely regulated to protect individual investors. Among the proposals: having hedge funds register with the Securities and Exchange Commission and raising the minimum net worth of individuals allowed to invest in hedge funds to $2.5 million from $1 million currently.

A recent report by the President's Working Group on Financial Markets, which included representatives of the SEC, Treasury, Commodities Futures Trading Commission and the Federal Reserve, said current regulations on hedge funds were sufficient.

But members of the committee, chaired by Rep. Barney Frank, D-Mass., expressed concern that average investors could be hurt without further oversight.

“We are now concerned about the inadvertent consequence of a systemic-like event which causes pensioners who have no idea their managers invested in a derivatives currency arbitrage to lose money as a result of a Russian currency crisis,” said Rep. Richard Baker, R-Louisiana.

But E. Gerald Corrigan, Goldman Sachs Managing Director, told the committee that rather than new rules, hedge funds should should improve their risk management and disclosure to lenders.

“While the probabilities of shocks are lower, the potential damage that can result from such shocks is greater due to the increase speed, complexity and tighter linkages that characterize the global financial system,” he said.

Opponents of additonal regulation say new rules would prevent some individual investors from taking advantage of a hedge fund’s strategy in bull and bear markets.


  • The Marriner S. Eccles Federal Reserve building in Washington.

    CNBC's Fed Survey shows market pros aren't very confident the Fed can end its easy money polices without a market crash, a recession or bad inflation.

  • Merck employees walk past a Merck sign in front of the company's building in Summit, New Jersey.

    Merck reported better-than-expected results, with sales of newer drugs offsetting declining sales of drugs facing generic competition.

  • Pfizer reported higher-than-expected second-quarter earnings, helped by growing sales of its cancer medicines.

  • An attendee is silhouetted against a Microsoft poster at the Microsoft Developers Build Conference in San Francisco, April 2, 2014.

    An agency that enforces antimonopoly laws visited company offices in four cities, as the country more closely scrutinizes multinational companies.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video